Ebola and the Race for a Vaccine

11 am

The Ebola virus continues to march across West Africa, with the latest numbers putting the death toll at over 2,000. Countries around the world are scrambling to develop a vaccine, but it could be months before it reaches those who need it most. This hour we’ll take a look at the science and the business of producing vaccines.

Guests

• Todd Frankel, Reporter for the Washington Post
• David W. Vaughn, Head of External Research and Development, North America at GlaxoSmithKline
• Ken Kaitin, Director of The Center for Drug Development at Tufts University